Volume 371, Issue 9625, Pages (May 2008)

Slides:



Advertisements
Similar presentations
Volume 14, Issue 4, Pages (April 2013)
Advertisements

Volume 385, Issue 9980, Pages (May 2015)
Enhanced performance feedback and patient participation to improve hand hygiene compliance of health-care workers in the setting of established multimodal.
Volume 357, Issue 9273, Pages (June 2001)
Volume 375, Issue 9729, Pages (May 2010)
Volume 376, Issue 9747, Pages (October 2010)
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant.
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant.
Volume 11, Issue 4, Pages (April 2012)
Volume 16, Issue 9, Pages (September 2015)
Volume 15, Issue 6, Pages (May 2014)
Volume 378, Issue 9809, Pages (December 2011)
Volume 388, Issue 10059, Pages (November 2016)
Volume 14, Issue 4, Pages (April 2013)
Volume 377, Issue 9779, Pages (May 2011)
Volume 377, Issue 9783, Pages (June 2011)
Volume 373, Issue 9666, Pages (March 2009)
Volume 366, Issue 9482, Pages (July 2005)
Volume 13, Issue 3, Pages (March 2012)
Volume 12, Issue 8, Pages (August 2011)
Volume 379, Issue 9823, Pages (April 2012)
Volume 12, Issue 2, Pages (February 2011)
Volume 15, Issue 4, Pages (April 2014)
Volume 14, Issue 12, Pages (December 2015)
Volume 385, Issue 9966, Pages (January 2015)
Volume 366, Issue 9482, Pages (July 2005)
Volume 15, Issue 4, Pages (April 2014)
Volume 373, Issue 9663, Pages (February 2009)
Volume 14, Issue 7, Pages (June 2013)
Volume 15, Issue 4, Pages (April 2014)
Volume 9, Issue 10, Pages (October 2008)
Volume 12, Issue 7, Pages (July 2011)
Volume 388, Issue 10059, Pages (November 2016)
Volume 375, Issue 9732, Pages (June 2010)
Volume 18, Issue 3, Pages (March 2017)
Volume 15, Issue 1, Pages (January 2014)
Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label,
Volume 387, Issue 10023, Pages (March 2016)
Volume 6, Issue 6, Pages (June 2005)
Volume 373, Issue 9666, Pages (March 2009)
Volume 10, Issue 9, Pages (September 2009)
Volume 381, Issue 9868, Pages (March 2013)
Volume 385, Issue 9962, Pages (January 2015)
Volume 19, Issue 4, Pages (April 2018)
Volume 15, Issue 8, Pages (July 2014)
Volume 373, Issue 9676, Pages (May 2009)
Volume 372, Issue 9647, Pages (October 2008)
Volume 18, Issue 8, Pages (August 2017)
Volume 388, Issue 10055, Pages (October 2016)
Volume 15, Issue 6, Pages (May 2014)
Volume 381, Issue 9880, Pages (May 2013)
Volume 392, Issue 10162, Pages (December 2018)
Volume 14, Issue 6, Pages (May 2013)
Volume 8, Issue 5, Pages (May 2009)
Volume 13, Issue 11, Pages (November 2012)
Volume 378, Issue 9809, Pages (December 2011)
Volume 373, Issue 9658, Pages (January 2009)
Volume 375, Issue 9714, Pages (February 2010)
Volume 15, Issue 6, Pages (May 2014)
Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial  Dr David Preiss, PhD, Suzanne M Lloyd,
Volume 11, Issue 3, Pages (March 2010)
Volume 11, Issue 1, Pages (January 2010)
Volume 18, Issue 10, Pages (October 2017)
Volume 375, Issue 9715, Pages (February 2010)
Volume 376, Issue 9747, Pages (October 2010)
Volume 13, Issue 5, Pages (May 2012)
Volume 372, Issue 9632, Pages (July 2008)
Volume 14, Issue 7, Pages (June 2013)
Volume 373, Issue 9680, Pages (June 2009)
Volume 3, Issue 1, Pages (January 2016)
Presentation transcript:

Volume 371, Issue 9625, Pages 1685-1694 (May 2008) Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial  Martin F Muers, FRCP, Richard J Stephens, Patricia Fisher, FRCR, Liz Darlison, BSc Hons, Christopher MB Higgs, MD, Erica Lowry, BA, Prof Andrew G Nicholson, DM, Mary O'Brien, MD, Michael Peake, FRCP, Robin Rudd, MD, Michael Snee, DM, Jeremy Steele, MD, David J Girling, FRCP, Matthew Nankivell, MSc, Cheryl Pugh, BSc Hons, Prof Mahesh KB Parmar, DPhil  The Lancet  Volume 371, Issue 9625, Pages 1685-1694 (May 2008) DOI: 10.1016/S0140-6736(08)60727-8 Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile After 3 years accrual, the trial design was changed to a two-group comparison by combining the two chemotherapy groups. The three-way randomisation was retained to allow some exploratory analyses of the two different chemotherapy groups. ASC=active symptom control. MVP=mitomycin, vinblastine, and cisplatin. V=vinorelbine. The Lancet 2008 371, 1685-1694DOI: (10.1016/S0140-6736(08)60727-8) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 2 Clinicians assessment of symptoms and side-effects (A) Proportion of patients with moderate or severe chest pain. (B) Proportion of patients with moderate or severe lethargy. Error bars indicate 95% CIs. ASC=active symptom control. MVP=mitomycin, vinblastine, and cisplatin. V=vinorelbine. The Lancet 2008 371, 1685-1694DOI: (10.1016/S0140-6736(08)60727-8) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 3 Mean standardised scores for the four predefined quality-of-life endpoints (A) Physical functioning; (B) pain; (C) dyspnoea; and (D) global quality of life. Error bars indicate 95% CIs. ASC=active symptom control. MVP=mitomycin, vinblastine, and cisplatin. V=vinorelbine. The Lancet 2008 371, 1685-1694DOI: (10.1016/S0140-6736(08)60727-8) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 4 Overall survival (A) Two-group comparison: ASC vs ASC plus chemotherapy. (B) Three-group comparison: ASC vs ASC plus MVP vs ASC plus vinorelbine. ASC=active symptom control. MVP=mitomycin, vinblastine, and cisplatin. V=vinorelbine. CT=chemotherapy. The Lancet 2008 371, 1685-1694DOI: (10.1016/S0140-6736(08)60727-8) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 5 Progression-free survival ASC=active symptom control. MVP=mitomycin, vinblastine, and cisplatin. V=vinorelbine. The Lancet 2008 371, 1685-1694DOI: (10.1016/S0140-6736(08)60727-8) Copyright © 2008 Elsevier Ltd Terms and Conditions